Dahiya, S., Ulrickson, M., Topp, M. S., Kersten, M. J., Yared, J., Reagan, P. M., Reshef, R., Sanderson, R., Voorhees, T., Ahmed, S., Jung, A. S., Granados, E., Dong, J., Winters, J., Shen, R., Kanska, J., Nahas, M., Nastoupil, L. J. (2025). A phase 1 study of KITE-363 anti-CD19/CD20 chimeric antigen receptor (CAR) T-cell therapy in patients (pts) with relapsed/refractory (R/R) B-cell lymphoma (BCL).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7003